Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Cervical Cancer

  Free Subscription


11.02.2019

1 Anticancer Agents Med Chem
1 Anticancer Drugs
3 Anticancer Res
2 Asian Pac J Cancer Prev
1 BMC Health Serv Res
1 BMJ
1 Brachytherapy
1 Cancer Epidemiol
1 Cancer Epidemiol Biomarkers Prev
1 Case Rep Oncol Med
2 Chem Biol Interact
1 Eur J Surg Oncol
4 Eur Rev Med Pharmacol Sci
1 Eur Urol
3 Gynecol Oncol
1 Gynecol Oncol Rep
2 Indian J Pathol Microbiol
2 Int J Gynecol Cancer
1 Int J Mol Sci
2 J Cancer
1 J Cell Physiol
1 J Clin Med
2 J Glob Oncol
1 J Photochem Photobiol B
1 J Virol
1 Lancet Glob Health
2 Lancet Oncol
1 LGBT Health
1 Mem Inst Oswaldo Cruz
1 Mol Med Rep
1 Molecules
1 Nanomedicine
1 Oncol Rep
1 Pathol Oncol Res
1 Pharmacol Res Perspect
1 Prim Care
1 Public Health
1 Rev Saude Publica
1 Sci Rep
1 Sensors (Basel)
3 Taiwan J Obstet Gynecol
1 Women Health


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Agents Med Chem

  1. HERNANDEZ SILVA CD, Leal AR, Ortiz-Lazareno PC, Jave Suarez LF, et al
    GPER Overexpression in Cervical Cancer Versus Premalignant Lesions: Its Activation Induces Different forms of Cell Death.
    Anticancer Agents Med Chem. 2019 Feb 6. pii: ACAMC-EPUB-96431.
    PubMed     Text format     Abstract available


    Anticancer Drugs

  2. CHEN R, Zhang L
    MiR-29a inhibits cell proliferation and migration by targeting the CDC42/PAK1 signaling pathway in cervical cancer.
    Anticancer Drugs. 2019 Feb 4. doi: 10.1097/CAD.0000000000000743.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. MATSUOKA H, Nakamura K, Matsubara Y, Ida N, et al
    Sarcopenia Is Not a Prognostic Factor of Outcome in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy or Radiotherapy.
    Anticancer Res. 2019;39:933-939.
    PubMed     Text format     Abstract available

  4. UNO T, Kanazawa A, Nemoto MW, Harada R, et al
    Radiation Therapy for Extrapelvic Lymph Node Recurrence After Curative Treatment for Cervical Cancer.
    Anticancer Res. 2019;39:891-895.
    PubMed     Text format     Abstract available

  5. TRYBUS W, Krol T, Trybus E, Stachurska A, et al
    Emodin Induces Death in Human Cervical Cancer Cells Through Mitotic Catastrophe.
    Anticancer Res. 2019;39:679-686.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  6. SAINEI NE, Kumar VS, Chin YS, Salih FAM, et al
    High Prevalence of Human Papillomavirus Types 56 and 70 Identified in the Native Populations of Sabah, Malaysia
    Asian Pac J Cancer Prev. 2018;19:2807-2813.
    PubMed     Text format     Abstract available

  7. OKUHARA T, Ishikawa H, Okada M, Kato M, et al
    Amount of Narratives Used on Japanese Pro- and Anti-HPV Vaccination Websites: A Content Analysis
    Asian Pac J Cancer Prev. 2018;19:2691-2694.
    PubMed     Text format     Abstract available


    BMC Health Serv Res

  8. WILLEMS B, Bracke P
    The impact of regional screening policies on the diffusion of cancer screening participation in Belgium: time trends in educational inequalities in Flanders and Wallonia.
    BMC Health Serv Res. 2018;18:943.
    PubMed     Text format     Abstract available


    BMJ

  9. DYER O
    Cervical cancer: deaths increase as HPV vaccine is underused, says WHO.
    BMJ. 2019;364:l580.
    PubMed     Text format    


    Brachytherapy

  10. MA TM, Harkenrider MM, Yashar CM, Viswanathan AN, et al
    Understanding the underutilization of cervical brachytherapy for locally advanced cervical cancer.
    Brachytherapy. 2019 Feb 2. pii: S1538-4721(18)30566.
    PubMed     Text format     Abstract available


    Cancer Epidemiol

  11. THI NGUYEN DN, Simms K, Vu Nguyen HQ, Van Tran T, et al
    The burden of cervical cancer in Vietnam: Synthesis of the evidence.
    Cancer Epidemiol. 2019;59:83-103.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  12. SPEES LP, Brewster WR, Varia MA, Weinberger M, et al
    Examining urban and rural differences in how distance to care influences the initiation and completion of treatment among insured cervical cancer patients.
    Cancer Epidemiol Biomarkers Prev. 2019 Feb 7. pii: 1055-9965.EPI-18-0945.
    PubMed     Text format     Abstract available


    Case Rep Oncol Med

  13. RODRIGUEZ-ROSALES YE, Salazar-Mejia CE, Soto-Martinez BA, Hernandez-Barajas D, et al
    Cardiac Tamponade as an Initial Manifestation of Cervical Cancer.
    Case Rep Oncol Med. 2019;2019:7524797.
    PubMed     Text format     Abstract available


    Chem Biol Interact

  14. XIA X, Xiang X, Huang F, Zheng M, et al
    Dietary canolol induces apoptosis in human cervical carcinoma HeLa cells through ROS-MAPK mediated mitochondrial signaling pathway: In vitro and in vivo.
    Chem Biol Interact. 2019;300:138-150.
    PubMed     Text format     Abstract available

  15. LIU X, Gan L, Zhang J
    miR-543 inhibites cervical cancer growth and metastasis by targeting TRPM7.
    Chem Biol Interact. 2019 Jan 30. pii: S0009-2797(18)31439.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  16. PAPADIA A, Morosi C, Wang J, Gasparri ML, et al
    SLN mapping in early-stage cervical cancer as a minimal-invasive triaging tool for multimodal treatment.
    Eur J Surg Oncol. 2019 Jan 30. pii: S0748-7983(19)30209.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  17. WANG DW, You D, Dong J, Liu TF, et al
    Knockdown of long non-coding RNA LINC00518 inhibits cervical cancer proliferation and metastasis by modulating JAK/STAT3 signaling.
    Eur Rev Med Pharmacol Sci. 2019;23:496-506.
    PubMed     Text format     Abstract available

  18. XIA N, Tan WF, Peng QZ, Cai HN, et al
    MiR-374b reduces cell proliferation and cell invasion of cervical cancer through regulating FOXM1.
    Eur Rev Med Pharmacol Sci. 2019;23:513-521.
    PubMed     Text format     Abstract available

  19. DAI SG, Guo LL, Xia X, Pan Y, et al
    Long non-coding RNA WT1-AS inhibits cell aggressiveness via miR-203a-5p/FOXN2 axis and is associated with prognosis in cervical cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:486-495.
    PubMed     Text format     Abstract available

  20. SHAN S, Li HF, Yang XY, Guo S, et al
    Higher lncRNA CASC15 expression predicts poor prognosis and associates with tumor growth in cervical cancer.
    Eur Rev Med Pharmacol Sci. 2019;23:507-512.
    PubMed     Text format     Abstract available


    Eur Urol

  21. OHLMANN CH, Hadaschik B
    Re: Minimally Invasive Versus Abdominal Radical Hysterectomy for Cervical Cancer.
    Eur Urol. 2019 Feb 1. pii: S0302-2838(19)30072.
    PubMed     Text format    


    Gynecol Oncol

  22. VASSILAKOS P, Poncet A, Catarino R, Viviano M, et al
    Cost-effectiveness evaluation of HPV self-testing offered to non-attendees in cervical cancer screening in Switzerland.
    Gynecol Oncol. 2019 Feb 1. pii: S0090-8258(19)30064.
    PubMed     Text format     Abstract available

  23. HUTCHCRAFT ML, Smith B, McLaughlin EM, Hade EM, et al
    Conization pathologic features as a predictor of intermediate and high risk features on radical hysterectomy specimens in early stage cervical cancer.
    Gynecol Oncol. 2019 Feb 2. pii: S0090-8258(19)30068.
    PubMed     Text format     Abstract available

  24. LOOPIK DL, Bekkers RLM, Massuger LFAG, Melchers WJG, et al
    Justifying conservative management of CIN2 in women younger than 25years - A population-based study.
    Gynecol Oncol. 2019;152:82-86.
    PubMed     Text format     Abstract available


    Gynecol Oncol Rep

  25. LEE EK, Lindeman NI, Matulonis UA, Konstantinopoulos PA, et al
    POLE-mutated clear cell cervical cancer associated with in-utero diethylstilbestrol exposure.
    Gynecol Oncol Rep. 2019;28:15-17.
    PubMed     Text format     Abstract available


    Indian J Pathol Microbiol

  26. PECORELLA I, Monti M, Dei Malatesta MLF, Ciardi G, et al
    Polyp of the uterine cervix with heterologous fatty tissue.
    Indian J Pathol Microbiol. 2018;61:593-595.
    PubMed     Text format     Abstract available

  27. HUANG ZY, Zhang S, Zhang YZ, An JH, et al
    The clinicopathologic and immunohistochemical features of villoglandular adenocarcinoma of uterine cervix.
    Indian J Pathol Microbiol. 2018;61:549-552.
    PubMed     Text format     Abstract available


    Int J Gynecol Cancer

  28. HUANG Y, He Q, Xu K, Zhou J, et al
    A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Int J Gynecol Cancer. 2019 Feb 7. pii: ijgc-2018-000095.
    PubMed     Text format     Abstract available

  29. ANGELES MA, Baissas P, Leblanc E, Lusque A, et al
    Magnetic resonance imaging after external beam radiotherapy and concurrent chemotherapy for locally advanced cervical cancer helps to identify patients at risk of recurrence.
    Int J Gynecol Cancer. 2019 Feb 1. pii: ijgc-2018-000168.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  30. KREMER WW, van Zummeren M, Heideman DAM, Lissenberg-Witte BI, et al
    HPV16-Related Cervical Cancers and Precancers Have Increased Levels of Host Cell DNA Methylation in Women Living with HIV.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    J Cancer

  31. GAO Y, Tang X, Cao J, Rong R, et al
    The Effect of HER2 Single Nucleotide Polymorphisms on Cervical Cancer Susceptibility and Survival in a Chinese Population.
    J Cancer. 2019;10:378-387.
    PubMed     Text format     Abstract available

  32. ZHANG X, Mao L, Li L, He Z, et al
    Long noncoding RNA GIHCG functions as an oncogene and serves as a serum diagnostic biomarker for cervical cancer.
    J Cancer. 2019;10:672-681.
    PubMed     Text format     Abstract available


    J Cell Physiol

  33. SHARMA A, De R, Javed S, Srinivasan R, et al
    Sonic hedgehog pathway activation regulates cervical cancer stem cell characteristics during epithelial to mesenchymal transition.
    J Cell Physiol. 2019 Feb 4. doi: 10.1002/jcp.28231.
    PubMed     Text format     Abstract available


    J Clin Med

  34. MATSUO K, Shimada M, Yamaguchi S, Kigawa J, et al
    Neoadjuvant Chemotherapy with Taxane and Platinum Followed by Radical Hysterectomy for Stage IB2-IIB Cervical Cancer: Impact of Histology Type on Survival.
    J Clin Med. 2019;8.
    PubMed     Text format     Abstract available


    J Glob Oncol

  35. TCHOUNZOU R, Simo Wambo AG, Njamen TN, Ilick IO, et al
    Patients Lost to Follow-Up for Cervical Cancer in the Limbe Regional Hospital.
    J Glob Oncol. 2019;:1-5.
    PubMed     Text format     Abstract available

  36. PERVIN S, Ruma FI, Rahman K, Ferdous J, et al
    Adjuvant Hysterectomy in Patients With Residual Disease After Radiation for Locally Advanced Cervical Cancer: A Prospective Longitudinal Study.
    J Glob Oncol. 2019;:1-7.
    PubMed     Text format     Abstract available


    J Photochem Photobiol B

  37. RASHMI R, Nedungadi D, Podder A, Mishra N, et al
    Monitoring of topoisomerase (I) inhibitor camptothecin release from endogenous redox-stimulated GO-polymer hybrid carrier.
    J Photochem Photobiol B. 2018;189:14-20.
    PubMed     Text format     Abstract available


    J Virol

  38. HE H, Liu X, Liu Y, Zhang M, et al
    Human papillomavirus E6/E7 and lncRNA TMPOP2 mutually upregulated gene expression in cervical cancer cells.
    J Virol. 2019 Feb 6. pii: JVI.01808-18. doi: 10.1128/JVI.01808.
    PubMed     Text format     Abstract available


    Lancet Glob Health

  39. KNAUL FM, Rodriguez NM, Arreola-Ornelas H, Olson JR, et al
    Cervical cancer: lessons learned from neglected tropical diseases.
    Lancet Glob Health. 2019 Feb 1. pii: S2214-109X(18)30533.
    PubMed     Text format    


    Lancet Oncol

  40. MALAGON T, Kulasingam S, Franco EL
    Limitations of simulation models for cervical cancer screening - Authors' reply.
    Lancet Oncol. 2019;20:e69.
    PubMed     Text format    

  41. HAMMER A, Landy R, Rositch AF, Gravitt PE, et al
    Limitations of simulation models for cervical cancer screening.
    Lancet Oncol. 2019;20:e68.
    PubMed     Text format    


    LGBT Health

  42. TABAAC AR, Benotsch EG, Barnes AJ
    Mediation Models of Perceived Medical Heterosexism, Provider-Patient Relationship Quality, and Cervical Cancer Screening in a Community Sample of Sexual Minority Women and Gender Nonbinary Adults.
    LGBT Health. 2019 Feb 5. doi: 10.1089/lgbt.2018.0203.
    PubMed     Text format     Abstract available


    Mem Inst Oswaldo Cruz

  43. CARESTIATO FN, Amaro-Filho SM, Moreira MAM, Cavalcanti SMB, et al
    Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples.
    Mem Inst Oswaldo Cruz. 2018;114:e180456.
    PubMed     Text format     Abstract available


    Mol Med Rep

  44. LI Y, Wang Y, Xie Z, Hu H, et al
    JMJD2A facilitates growth and inhibits apoptosis of cervical cancer cells by downregulating tumor suppressor miR4915p.
    Mol Med Rep. 2019 Jan 31. doi: 10.3892/mmr.2019.9916.
    PubMed     Text format     Abstract available


    Molecules

  45. ABOUL-SOUD MAM, Al-Amri MZ, Kumar A, Al-Sheikh YA, et al
    Specific Cytotoxic Effects of Parasporal Crystal Proteins Isolated from Native Saudi Arabian Bacillus thuringiensis Strains against Cervical Cancer Cells.
    Molecules. 2019;24.
    PubMed     Text format     Abstract available


    Nanomedicine

  46. ZHANG X, Luo L, Li L, He Y, et al
    Trimodal synergistic antitumor drug delivery system based on graphene oxide.
    Nanomedicine. 2019;15:142-152.
    PubMed     Text format     Abstract available


    Oncol Rep

  47. LI X, Wu X, Li Y, Cui Y, et al
    Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
    Oncol Rep. 2019 Feb 1. doi: 10.3892/or.2019.6993.
    PubMed     Text format     Abstract available


    Pathol Oncol Res

  48. KAR S, Majumder DD
    A Novel Approach of Mathematical Theory of Shape and Neuro-Fuzzy Based Diagnostic Analysis of Cervical Cancer.
    Pathol Oncol Res. 2019 Feb 6. pii: 10.1007/s12253-019-00582.
    PubMed     Text format     Abstract available


    Pharmacol Res Perspect

  49. KERN S, Truebenbach I, Hohn M, Gorges J, et al
    Combined antitumoral effects of pretubulysin and methotrexate.
    Pharmacol Res Perspect. 2019;7:e00460.
    PubMed     Text format     Abstract available


    Prim Care

  50. STUMBAR SE, Stevens M, Feld Z
    Cervical Cancer and Its Precursors: A Preventative Approach to Screening, Diagnosis, and Management.
    Prim Care. 2019;46:117-134.
    PubMed     Text format     Abstract available


    Public Health

  51. YOU H, Gu H, Zhang N, Fan H, et al
    Why hasn't this woman been screened for breast and cervical cancer? - Evidence from a Chinese population-based study.
    Public Health. 2019;168:83-91.
    PubMed     Text format     Abstract available


    Rev Saude Publica

  52. LEITE FMC, Amorim MHC, Gigante DP
    Implication of violence against women on not performing the cytopathologic test.
    Rev Saude Publica. 2018;52:89.
    PubMed     Text format     Abstract available


    Sci Rep

  53. GILLANI SW, Zaghloul HA, Ansari IA, Abdul MIM, et al
    Multivariate Analysis on the Effects of Diabetes and related Clinical Parameters on Cervical Cancer Survival Probability.
    Sci Rep. 2019;9:1084.
    PubMed     Text format     Abstract available


    Sensors (Basel)

  54. CHOI H, Choe SW
    Acoustic Stimulation by Shunt-Diode Pre-Linearizer using Very High Frequency Piezoelectric Transducer for Cancer Therapeutics.
    Sensors (Basel). 2019;19.
    PubMed     Text format     Abstract available


    Taiwan J Obstet Gynecol

  55. JI X, Chen F, Zhou Y, Li J, et al
    Copy number variation profile in noninvasive prenatal testing (NIPT) can identify co-existing maternal malignancies: Case reports and a literature review.
    Taiwan J Obstet Gynecol. 2018;57:871-877.
    PubMed     Text format     Abstract available

  56. WANG YC, Yu YL, Fan CW, Huang SY, et al
    Primary signet ring cell carcinoma of the cervix: A case report with review of the literature.
    Taiwan J Obstet Gynecol. 2018;57:862-866.
    PubMed     Text format     Abstract available

  57. TSAI LY, Lee SC, Wang KL, Tsay SL, et al
    A correlation study of fear of cancer recurrence, illness representation, self-regulation, and quality of life among gynecologic cancer survivors in Taiwan.
    Taiwan J Obstet Gynecol. 2018;57:846-852.
    PubMed     Text format     Abstract available


    Women Health

  58. GORDON JR, Barve A, Chaudhari V, Kosambiya JK, et al
    "HIV is not an easily acceptable disease": the role of HIV-related stigma in obtaining cervical cancer screening in India.
    Women Health. 2019 Feb 4:1-14. doi: 10.1080/03630242.2019.1565903.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: